Advertisement
Surgery for Obesity and Related Diseases
ASMBS
Advanced searchSave search
Editorial comment| Volume 13, ISSUE 7, P1157-1158, July 2017

Is the intestinal microbiome a modifiable cofactor in the development of hyperoxaluria after Roux-en-Y gastric bypass?

Published:May 04, 2017DOI:https://doi.org/10.1016/j.soard.2017.05.001
Is the intestinal microbiome a modifiable cofactor in the development of hyperoxaluria after Roux-en-Y gastric bypass?
Previous ArticleOxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria
Next ArticleDumping symptoms is triggered by fat as well as carbohydrates in patients operated with Roux-en-Y gastric bypass
      Patients with enteric hyperoxaluria hyperabsorb oxalate from their diet. In healthy individuals, only a minority of ingested oxalate is absorbed (~10%). However, this percentage increases to 10%–30% among patients with enteric hyperoxaluria [
      • Hesse A.
      • Schneeberger W.
      • Engfeld S.
      • Von Unruh G.E.
      • Sauerbruch T.
      Intestinal hyperabsorption in calcium oxlate stone formers: application of a new test with [13 C2] oxalate.
      J Am Soc Nephrol. 1999; 10: S329-S333
      ]. Known and modifiable determinants of oxalate absorption from the diet include the absolute and relative amounts of oxalate, fat, and calcium eaten.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Hesse A.
        • Schneeberger W.
        • Engfeld S.
        • Von Unruh G.E.
        • Sauerbruch T.
        Intestinal hyperabsorption in calcium oxlate stone formers: application of a new test with [13 C2] oxalate.
        J Am Soc Nephrol. 1999; 10: S329-S333
        View in Article
        • Nazzal L.
        • Puri S.
        • Goldfarb D.S.
        Enteric hyperoxaluria: an important cause of end-stage kidney disease.
        Nephrol Dial Transplant. 2016; 31: 375-382
        View in Article
        • McDonald G.B.
        • Earnest D.L.
        • Admirand W.H.
        Hyperoxaluria correlates with fat malabsorption in patients with sprue.
        Gut. 1977; 18: 561-566
        View in Article
        • Requarth J.A.
        • Burchard K.W.
        • Colacchio T.A.
        • et al.
        Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal.
        Arch Surg. 1995; 130: 318-325
        View in Article
        • Angrisani L.
        • Santonicola A.
        • Iovino P.
        • Formisano G.
        • Buchwald H.
        • Scopinaro N.
        Bariatric Surgery Worldwide 2013.
        Obes Surg. 2015; 25: 1822-1832
        View in Article
        • Lieske J.C.
        • Mehta R.A.
        • Milliner D.S.
        • Rule A.D.
        • Bergstralh E.J.
        • Sarr M.G.
        Kidney stones are common after bariatric surgery.
        Kidney Int. 2015; 87: 839-845
        View in Article
        • Hoppe B.
        • Beck B.
        • Gatter N.
        • et al.
        Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
        Kidney Int. 2006; 70: 1305-1311
        View in Article
        • Siener R.
        • Bangen U.
        • Sidhu H.
        • Hönow R.
        • von Unruh G.
        • Hesse A.
        The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
        Kidney Int. 2013; 83: 1144-1149
        View in Article
        • Kaufman D.W.
        • Kelly J.P.
        • Curhan G.C.
        • et al.
        Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.
        J Am Soc Nephrol. 2008; 19: 1197-1203
        View in Article
        • Hatch M.
        • Gjymishka A.
        • Salido E.C.
        • Allison M.J.
        • Freel R.W.
        Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
        Am J Physiol Gastrointest Liver Physiol. 2011; 300: G461-G469
        View in Article

      Article info

      Publication history

      Published online: May 04, 2017

      Identification

      DOI: https://doi.org/10.1016/j.soard.2017.05.001

      Copyright

      © 2017 Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX